[18F]FLT PET for Non-Invasive Monitoring of Early Response to Gene Therapy in Experimental Gliomas (original) (raw)
Dynamic Small-Animal PET Imaging of Tumor Proliferation with 3'-Deoxy-3'-18F-Fluorothymidine in a Genetically Engineered Mouse Model of High-Grade Gliomas
Valerie Longo
Journal of Nuclear Medicine, 2008
View PDFchevron_right
Dynamic Small-Animal PET Imaging of Tumor Proliferation with 39-Deoxy-39-18F- Fluorothymidine in a Genetically Engineered Mouse Model of High-Grade Gliomas
Valerie Longo
2000
View PDFchevron_right
Imaging-Guided Gene Therapy of Experimental Gliomas
Wolf-dieter Heis
Cancer Research, 2007
View PDFchevron_right
18F-fluorothymidine-pet imaging of glioblastoma multiforme: effects of radiation therapy on radiotracer uptake and molecular biomarker patterns
Gary Kao
TheScientificWorldJournal, 2013
View PDFchevron_right
Glioma Proliferation as Assessed by 3'-Fluoro-3'-Deoxy-L-Thymidine Positron Emission Tomography in Patients with Newly Diagnosed High-Grade Glioma
Wolf-dieter Heis
Clinical Cancer Research, 2008
View PDFchevron_right
Evaluation of 9-[(3-18F-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]-FHPG) in vitro and in vivo as a probe for PET imaging of gene incorporation and expression in tumors
Erlinda Gordon
Nuclear Medicine and Biology, 1999
View PDFchevron_right
Imaging regional variation of cellular proliferation in gliomas using 3′-deoxy-3′-[18F]fluorothymidine positron-emission tomography: an image-guided biopsy study
Raymond Salvador
Clinical Radiology, 2009
View PDFchevron_right
NCI-Sponsored Trial for the Evaluation of Safety and Preliminary Efficacy of 3′-Deoxy-3′-[18F]fluorothymidine (FLT) as a Marker of Proliferation in Patients with Recurrent Gliomas: Preliminary Efficacy Studies
Lalitha Shankar
Molecular Imaging and Biology, 2009
View PDFchevron_right
Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG
Marvin Bergsneider, Linda Liau
Journal of Nuclear …, 2005
View PDFchevron_right
Utility of 3'-[(18)F]fluoro-3'-deoxythymidine as a PET tracer to monitor response to gene therapy in a xenograft model of head and neck carcinoma
malabika sen
American Journal of Nuclear Medicine and Molecular Imaging, 2013
View PDFchevron_right
Early Assessment of the Efficacy of Temozolomide Chemotherapy in Experimental Glioblastoma Using [18F]FLT-PET Imaging
Thomas Viel
PLoS ONE, 2013
View PDFchevron_right
Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas
Martin Lercher, R. Reszka
The Lancet, 2001
View PDFchevron_right
Molecular PET and PET/CT imaging of tumour cell proliferation using F-18 fluoro-L-thymidine: a comprehensive evaluation
James Mountz
Nuclear Medicine Communications, 2009
View PDFchevron_right
Fluorothymidine as a New Marker for Monitoring Tumor Response to Antiproliferative Therapy in Vivo with Positron Emission Tomography 1
Clyde Hutchinson
2003
View PDFchevron_right
Technical feasibility of [18F]FET and [18F]FAZA PET guided radiotherapy in a F98 glioblastoma rat model
Julie Bolcaen
Radiation Oncology
View PDFchevron_right
(2S, 4R)-4-[18F]Fluoroglutamine for In vivo PET Imaging of Glioma Xenografts in Mice: an Evaluation of Multiple Pharmacokinetic Models
Anne Roivainen
Molecular Imaging and Biology
View PDFchevron_right
3'-Deoxy-3'-18F-Fluorothymidine PET-Derived Proliferative Volume Predicts Overall Survival in High-Grade Glioma Patients
Jeroen Boogaarts
Journal of Nuclear Medicine, 2012
View PDFchevron_right
Role of PET in the management of gliomas: The radiopharmacist's and clinician's point of view
P. Payoux
Médecine Nucléaire, 2015
View PDFchevron_right
O-(2-18F-Fluoroethyl)-L-Tyrosine PET Predicts Failure of Antiangiogenic Treatment in Patients with Recurrent High-Grade Glioma
Daniel Putzer
Journal of Nuclear Medicine, 2011
View PDFchevron_right
Kinetic analysis of 3′-deoxy-3′-18F-fluorothymidine in patients with gliomas
Mark Muzi
Journal of Nuclear …, 2006
View PDFchevron_right
Glioma FMISO PET/MR Imaging Concurrent with Antiangiogenic Therapy: Molecular Imaging as a Clinical Tool in the Burgeoning Era of Personalized Medicine
Miguel Hernandez Pampaloni
Biomedicines, 2016
View PDFchevron_right
[68Ga]RGD Versus [18F]FDG PET Imaging in Monitoring Treatment Response of a Mouse Model of Human Glioblastoma Tumor with Bevacizumab and/or Temozolomide
aurelie prignon
Molecular Imaging and Biology, 2018
View PDFchevron_right
Repeatability of 18F-FLT PET in a Multi-Center Study of Patients with High Grade Glioma
James Mountz
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016
View PDFchevron_right
NCI-Sponsored Trial for the Evaluation of Safety and Preliminary Efficacy of FLT as a Marker of Proliferation in Patients with Recurrent Gliomas: Safety Studies
Mark Muzi
Molecular Imaging and Biology, 2008
View PDFchevron_right
Comparison of 18F-FET and 18F-FLT small animal PET for the assessment of anti-VEGF treatment response in an orthotopic model of glioblastoma
Ulrik Lassen
Nuclear Medicine and Biology, 2016
View PDFchevron_right
[18F]FLT–PET Imaging Does Not Always “Light Up” Proliferating Tumor Cells
Ken Zasadny
Clinical Cancer Research, 2011
View PDFchevron_right
Impact of [18F]-fluoro-ethyl-tyrosine PET imaging on target definition for radiation therapy of high-grade glioma
Junia Costa, Svend Engelholm
Neuro-oncology, 2014
View PDFchevron_right
3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography
David Collingridge
Cancer research, 2003
View PDFchevron_right
Fluorine-18-labeled fluoroboronophenylalanine PET in patients with glioma
Yoshio Imahori
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1998
View PDFchevron_right
Reproducibility of the kinetic analysis of 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography in mouse tumor models
Sang-we Kim
Nuclear Medicine and Biology, 2009
View PDFchevron_right
Positron-emission tomography monitoring of anti-glioblastoma HSV-1-tk gene therapy
S. Vollmar
Gene Therapy and Regulation, 2003
View PDFchevron_right
FDG-PET imaging for the evaluation of antiglioma agents in a rat model
Antonio Aliaga
Neuro-Oncology, 2008
View PDFchevron_right